EUVIMEDEUVIMED entdecken
Crossref

Etiology and clinical course of severe and extreme thrombocytosis in children: a retrospective single-center study

Kenji Kishimoto, Daiichiro Hasegawa, Yasuo Nakagishi, Hiroshi Kurosawa, Toshikatsu Tanaka, Tadashi Hatakeyama, Yoshihiro Oshima, Yoshiyuki Kosaka

European Journal of Pediatrics · 2024

DOI: 10.1007/s00431-024-05755-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Kenji Kishimoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan. ken@yacht.ocn.ne.jp. Hauptthemen laut MEDLINE: Thrombocytosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to describe the etiology and clinical course in children with severe thrombocytosis (ST, platelet counts > 900 × 109/L) and extreme thrombocytosis (ET, platelet counts > 1000 × 109/L) in a tertiary pediatric hospital. Patients aged 0-18 years with platelet counts over 900 × 109/L who were admitted to our hospital were analyzed. Thrombocytosis was defined as a platelet count exceeding 450 × 109/L. Thrombosis was diagnosed based on computed tomography scans or ultrasound findings. Potential factors associated with the development of extreme thrombocytosis were identified using logistic regression models. Only one (0.8%) out of the 120 patients identified with ST (n = 61) and ET (n = 59) had primary thrombocytosis. The most common underlying condition was congenital heart disease (26.7%), followed by Kawasaki disease (16.7%). With the exception of the hemoglobin level, no major differences were found for the baseline characteristics between the ST and ET groups. A lower hemoglobin level (< 10.0 g/dL) at the onset of thrombocytosis was identified as a predictor for ET development (adjusted odds ratio 2.73, 95% confidence interval 1.18-6.28). Overall, 56 of 120 (46.7%) patients received aspirin therapy. Venous thrombosis occurred in one (0.8%) patient. CONCLUSIONS: We found a low proportion of primary thrombocytosis and a low incidence of thrombosis in children with ST and ET. Our results suggest that pediatric ST and ET may share common characteristics and may have features that are distinct from those in adults. WHAT IS KNOWN: • Secondary thrombocytosis is a frequent finding in children. • Adult extreme thrombocytosis has been found to be associated with primary thrombocytosis. WHAT IS NEW: • There were no major differences in the baseline characteristics between children with severe and extreme thrombocytosis. • The incidence of thrombosis was markedly low in both severe and extreme thrombocytosis groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytosisHumansFemaleMaleRetrospective StudiesChildInfantChild, PreschoolAdolescentInfant, NewbornPlatelet CountThrombosisSeverity of Illness IndexLogistic ModelsRisk Factors

Stichwörter der Autor:innen

ChildrenPlatelet countThrombocytosisThrombosis

Autor:innen und Institutionen

  • Department of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan. ken@yacht.ocn.ne.jp.
  • Department of Hematology & Oncology, Kobe Children's Hospital, Minatojima-Minamimachi 1-6-7, Chuo-Ku, Kobe, 650-0047, Japan.
  • Department of General Pediatrics, Kobe Children's Hospital, Kobe, Japan.
  • Division of Pediatric Critical Care Medicine, Kobe Children's Hospital, Kobe, Japan.
  • Department of Cardiology, Kobe Children's Hospital, Kobe, Japan.
  • Department of Pediatric Surgery, Kobe Children's Hospital, Kobe, Japan.

Zitieren

APA

Kishimoto, K., Hasegawa, D., Nakagishi, Y., Kurosawa, H., Tanaka, T., Hatakeyama, T., Oshima, Y., & Kosaka, Y. (2024). Etiology and clinical course of severe and extreme thrombocytosis in children: a retrospective single-center study. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05755-5

Vancouver

Kishimoto K, Hasegawa D, Nakagishi Y, Kurosawa H, Tanaka T, Hatakeyama T, et al. Etiology and clinical course of severe and extreme thrombocytosis in children: a retrospective single-center study. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05755-5

BibTeX
@article{Kishimoto2024,
  author = {Kishimoto, Kenji and Hasegawa, Daiichiro and Nakagishi, Yasuo and Kurosawa, Hiroshi and Tanaka, Toshikatsu and Hatakeyama, Tadashi and Oshima, Yoshihiro and Kosaka, Yoshiyuki},
  title = {Etiology and clinical course of severe and extreme thrombocytosis in children: a retrospective single-center study},
  journal = {European Journal of Pediatrics},
  year = {2024},
  doi = {10.1007/s00431-024-05755-5}
}
Kostenlos starten →